ArticleCureus2025
Only-Glue Fixation in Laparoscopic Intraperitoneal Onlay Mesh Repair of Midline Ventral Hernias: Technical Aspects and Short-Term Results of 40 Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multicentric pragmatic randomized controlled trial of mesh fixation system in primary and recurrent ventral hernia repair.Updates in surgery · 2026Article
- Evaluation of NBCA(n-butyl-2-cyanoacrylate) surgical glue for mesh fixation in laparoscopic treatment of primary lateral incisional hernias.Hernia : the journal of hernias and abdominal wall surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesh fixation remains a key challenge in laparoscopic hernia repair, with no universally accepted technique established to date. This study investigates the clinical application of cyanoacrylate (CA) as the sole fixation method in laparoscopic intraperitoneal onlay mesh (IPOM) repair for midline ventral hernias. A retrospective analysis of patients with midline ventral hernias who underwent IPOM-only glue (IPOM-OG) repair from September 2022 to December 2023 has been carried out. Follow-up was available in 34 (85%) of 40 patients who were operated on during the study period. The majority were primary umbilical hernias, with an average width of 3 cm. Closure of the defect (IPOM +) was performed in 25 (74%) cases, the average hernia-mesh size ratio was 1:16, and the operative time was 64 (40-90) minutes. Two (6%) pseudo-hernias (seroma at the residual sac) were successfully treated with fine-needle percutaneous aspiration. Postoperative visual analog scale (VAS) score of pain in two different measures was low, and no patient complained of chronic pain. Two patients underwent another laparoscopic procedure (cholecystectomy) 14 and 90 days after IPOM-OG, respectively. In both cases, we could confirm that the mesh was adequately positioned without disruptions, wrinkles, bulges, or curled edges. After a median follow-up of 16 (12-26) months, no recurrences or abdominal bulging have been detected. Our proposed technique provides additional data regarding the use of CA as a sole fixation method in IPOM repair of midline ventral hernias. It resulted in a reduction of chronic pain, without jeopardizing the safety of the repair. IPOM-OG may be a suitable option in properly selected patients with small midline hernia defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.